HIV i-Base accounts and funding for 2015/16

i-Base would like to thank all funders for their continued support, without which our work would not have been possible.

Accounts chart 1

Accounts chart 1

Accounts chart 2

CATEGORIES OF EXPENDITURE AMOUNT (£) DESCRIPTION
Fundraising costs 7,997
Publications
119,258
HTB, patient guides and forms, foreign translations
Phone line/information officer 38,494 Phone line services, email Q&A, information requests
Website
10,521
Maintenance, online publications, historical database
UK CAB 51,831 UK Community Advisory Board quarterly meetings
Community outreach 3,317 Work with community organisations in the UK
Community outreach overseas 25,232 Work with community organisations abroad
Research and other partnerships 58,325 Patient representation and research partnerships
External conferences
32,949
Attendance at medical and other conferences
AfroCAB 58,901 Secretariat services for AfroCab African community advocates
Management and administration 30,668 Including additional costs related to relocation
Governance costs
5,280
Total
442,773

Major funders 2015/16

Only grants of £1,000 or over are listed separately.

ORGANISATION AMOUNT (£) PROJECT TO WHICH FUNDS ALLOCATED
Charitable bodies and organisations, private donations and other income
The Monument Trust 275,000 Treatment Information, HTB, HTB South, publications, website, work in Southern Africa.
University College Hospital 12,576 Research collaboration
Publisher’s licensing 3,544 Copyright fees
Royal Free 1,510 NIHR programme participation
Brighton & Sussex University Hospital 5,156 Research collaboration (SUPA)
University of Minnesotta  20,689 Research collaboration
UNITAID 1,301 Research project
Virology Education 2,388 Research project
WHO 5,070 Research project
Other small grants and income 1,789 Small grants, advisory honoraria, bank interest etc
Sub-total 330,116
Pharmaceutical industry
Bristol Myers-Squibb
3,000
UK-CAB
Gilead Sciences Limited
11,638
Treatment information, core funding and UK-CAB
Janssen
3,000
UK-CAB
ViiV Healthcare 18,136 Treatment information service and UK-CAB
Awards for All 10,000 UK-CAB training course
Sub-total 45,774
Charitable and Pharmaceutical Industry support received on behalf of AfroCAB
Janssen 12,665
Gilead Sciences Limited 79,590
ViiV Healthcare 20,119
WHO 8,148
Sub Total income received on behalf of AfroCAB 120,512
Total income for the year
496,402

Annual summary accounts (PDF files)

Year ended 31 March 2016 (880 Kb)

Year ended 31 March 2015 (700 Kb)

Year ended 31 March 2014 (680 Kb)

Year ended 31 March 2013 (640 Kb)

Year ended 31 March 2012 (640 Kb)

Year ended 31 March 2011 (590 Kb)

Year ended 31 March 2010 (700 Kb)

Year ended 31 March 2009 (1.7 MB)

Year ended 31 March 2008 (686 Kb)

Year ended 31 March 2007 (60 Kb)

Year ended 31 March 2006 (56 Kb)

Year ended 31 March 2005 (48 Kb)

Year ended 31 March 2004 (40 Kb)

Year ended 31 March 2003 (36 Kb)

Year ended 31 March 2002 (40 Kb)

Last updated: 12 January 2017